MedPath

se of Moringa Oleifera in gum disease

Phase 4
Conditions
Health Condition 1: K053- Chronic periodontitis
Registration Number
CTRI/2023/03/050332
Lead Sponsor
Dr Pradumna Nandkishor Niturkar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients with chronic periodontitis (moderate and severe) according to CDC criteria 2007.

2. Systemically healthy patients.

3. Presence of minimum 20 teeth.

Exclusion Criteria

1. Patients who have taken anti-inflammatory/antibiotic therapy prior to one month of beginning of study.

2. Tobacco habit in any form and alcoholics.

3. Pregnant and lactating women.

4. Patient with known allergy to Moringa oleifera / patient with confirmed intolerance to

Moringa oleifera.

5. Subjects who have undergone periodontal treatment within six months of start of study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gingival Index, plaque index, probing depth, sulcus bleeding index, clinical attachment gainTimepoint: After 4 and 6 weeks of start of intervention
Secondary Outcome Measures
NameTimeMethod
Serum Highly Sensitive C reactive proteinTimepoint: After 4 weeks of start of intervention
© Copyright 2025. All Rights Reserved by MedPath